I agree with you that the market is underestimating the opportunity here - but why do you think that is? I don't think it all rests on simply getting FDA or not - maybe a little bit, but not multiple bags. I think the market seems to have largely priced in what we know is almost a certainty. I've often wondered before if it is simply because our supposed primary competition, Qbrexza, only earns something like $25m/yr in this market. But the research conducted shows a market with immediate potential of hundreds of millions. If we simply replicate Japan's performance we should be looking at $100m revenue (which easily prices BOT with a $ sign). Is the market just that fickle in this current state and BOT needs to demonstrate sales first before we get significant SP improvement, or do you think there are other reasons?
- Forums
- ASX - By Stock
- BOT
- Bot Chart
Bot Chart, page-8233
-
-
- There are more pages in this discussion • 5,524 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
|
|||||
Last
38.0¢ |
Change
0.055(16.9%) |
Mkt cap ! $687.8M |
Open | High | Low | Value | Volume |
33.0¢ | 38.0¢ | 33.0¢ | $7.103M | 19.63M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 134000 | 37.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
38.0¢ | 650314 | 19 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 132500 | 0.375 |
3 | 7752 | 0.370 |
2 | 24000 | 0.365 |
1 | 4166 | 0.360 |
3 | 59669 | 0.355 |
Price($) | Vol. | No. |
---|---|---|
0.380 | 502144 | 15 |
0.385 | 164500 | 4 |
0.390 | 276986 | 11 |
0.395 | 750000 | 5 |
0.400 | 660032 | 20 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |